Ask a Question
  
  
  
Top Posters
Since Sunday
28
27
27
26
25
24
24
23
23
22
22
22
New Topic  
wrote...
Posts: 25
Rep: 0 0
2 weeks ago
A patient is undergoing a cytotoxic chemotherapy regimen for the treatment of stage III lung cancer. What effect will this regimen likely have on the patient's hemostatic function?
A)The patient's platelet count will decline.
B)The patient will be at increased risk of deep vein thrombosis.
C)The patient will require prophylactic heparin.
D)The patient will likely experience thrombocytosis.
Source  Download
Abrams' Clinical Drug Therapy: Rationales for Nursing Practice
Edition: 10th
Authors:
Read 4 times
1 Reply
Replies
Answer verified by a subject expert
wrote...
Posts: 74
2 weeks ago
Sign in or Sign up in seconds to unlock everything.
A
Feedback:
Thrombocytopenia is a common adverse effect of cytotoxic chemotherapy. Heparin is consequently contraindicated, and DVT is not a priority risk.

Related Topics
New Topic      
Explore
Post your homework questions and get free online help from our incredible volunteers.
Learn More
Improve Grades
Help Others
Save Time
Accessible 24/7
  56 People Browsing
Related Images
 287
 145
 76